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Abstract.  To establish the relation of glycosaminogly- 
can synthesis to cell proliferation, we investigated the 
synthesis of individual glycosaminoglycan species by 
intact cells and in a  cell-free system, using normal and 
transformed human fibroblasts under differing culture 
conditions. Reducing serum concentration brought 
about a  marked decline in the synthesis of hyaluronate 
(HA) as well as cell proliferation on both normal and 
transformed cells. Both HA synthesis and proliferation 
decreased with increasing cell densities markedly (in 
inverse proportion to cell density) in normal cells but 
gradually in transformed cells. This noticeable con- 
gruity of the changes in HA synthesis and proliferation 
indicates that the change in HA synthesis is related 
primarily to cell proliferation rather than to cell den- 
sity or cellular transformation. Examination of HA 
synthesis in a cell-free system demonstrated that the 
activity of HA synthetase also fluctuated in conjunc- 
tion with cell proliferation. Furthermore, growth- 
reduced cells (except crowded transformed cells) 
inhibited cell-free HA synthesis and this inhibition was 
induced coincidentally with a decrease in both HA 
synthetase activity and proliferation. These findings 
suggest that the change in HA synthesis is significant 
in the regulation of cell proliferation. 
M 
OST animal ceils in vivo and in vitro produce the 
polyanionic macromolecu!es generically termed 
glycosaminoglycans (GAGs) 1 and proteoglycans, 
which are distributed on the cell surface and in subcellular 
constituents as well as the extracellular matrix and connec- 
tive tissues (19, 22, 47).  GAG's consist of a variety of sub- 
species such as hyaluronate (HA), heparan sulfate (HS), and 
galactosaminoglycans (GalAG's), which include chondroitin 
sulfates and dermatan sulfate. The GAG species, with the ex- 
ception of HA, are originally synthesized on protein cores 
to form proteoglycans. Recent studies on GAG's and pro- 
teoglycans suggest that these substances are not only the sub- 
strate materials of connective tissues but that they also play 
diverse roles in the regulation of cellular functions (15, 19, 
22, 47). It has been demonstrated that treatment with exoge- 
nous GAG's and proteoglycans, especially HS, affects cell 
proliferation (11, 23, 32, 34, 57), suggesting that GAG's and 
proteoglycans are involved in the regulation of cell prolifera- 
tion such as density-dependent growth inhibition (30). 
1.  Abbreviations  used  in  this paper:  GAG,  glycosaminoglycan;  GalAG, 
galactosaminoglycan;  HA, hyaluronate; HAS, hyaluronate synthetase; HAS 
inhibition, inhibition of cell-free hyaluronate  synthesis; HexUA, hexuronic 
acid;  HS,  heparan sulfate;  UDP-GlcUA,  uridine 5'-diphosphoglucuronic 
acid. 
In this connection, there have been a number of studies on 
the synthesis and composition of GAG's and proteoglycans 
in relation to the cell cycle (25, 46), cell density (7), transfor- 
mation (20), aging (1, 31, 52), and other factors related to cell 
proliferation (for reviews see references  19, 22,  47).  In a 
general sense these studies show that cells actively synthe- 
size HA and chondroitin sulfates in the growing phase but 
tend to synthesize HS and dermatan sulfate in the stationary 
phase of cell proliferation. However, the general features of 
GAG's in relation to cell proliferation remain to be estab- 
lished, because a  complicated concomitance.of the above 
factors interferes with a decisive attribution of the observed 
changes in GAG's to any one factor.  Concerning this issue, 
we recently found that the changes in cell-associated HA and 
HS relate mainly to the state of cell growth (33).  This moti- 
vated  us  to  further  investigate  the  relationship  between 
GAG's and cell proliferation. 
Here  we describe a  detailed analysis of growth-related 
changes in GAG synthesis using normal and transformed hu- 
man fibroblasts under various culture conditions, the results 
establishing  a  tight  coupling  of  HA  synthesis  with  cell 
proliferation. Furthermore, we report that various growth- 
reduced cells (except  crowded transformed cells) inhibited 
HA synthesis in a cell-free system and that this inhibition was 
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of HA synthetase (HAS) and cell proliferation.  These find- 
ings suggest that the change in HA synthesis is significant in 
the regulation of cell proliferation. 
Materials and Methods 
Cell Cultures and Materials 
The following cell strains were used: WI-38 (human embryonic lung fibro- 
blasts, ATCC CCL 75; middle passage cells at a population doubling level 
of 34--40),  WI-38  CT-1 (6°Co-transformed WI-38  cells  [42,  43]),  and 
BALB/3T3 (mouse embryonic cells, ATCC CCL 163). Cells were supplied 
from a cell depository in liquid nitrogen and subcultured at least twice be- 
fore use. Unless otherwise specified, cells were cultured in DME (No. 430- 
2100, 4.5 g/liter of D-glucose; Gibco, Grand Island, NY) supplemented with 
10% FBS (No. 210471, Boehringer Mannheim GmbH, Mannheim, Federal 
Republic of  Germany) and 100 gg/ml of  kanamycin sulfate throughout main- 
tenance and experiments as previously described (31). 
Radioisotope-labeled compounds were purchased from the Radiochemi- 
cal Centre (Amersham, England); GAG lyases and authentic GAG's (except 
HS prepared from bovine kidney [32])  were from Seikagaku Kogyo Co. 
(Tokyo,  Japan); and commercial grade chemicals were from Wako  Pure 
Chemical Industries (Osaka, Japan) unless otherwise indicated. 
Assay of  GAG Synthesis by Intact Cells 
Cells were inoculated into 90-mm dishes (45 cm2/dish, No. 3003,  Falcon 
Labwares, Oxnard, CA) at various cell densities and cultured for 2 d  (or 
for 5 d to obtain dense cultures, which received fresh medium 2 d before 
labeling). In subsequent sections, the term "serum" means the above FBS 
and the terms "sparse" and "dense" (or "crox~led') indicate cell densities of 
0.5-2.0 x  104 cells/cm  2 and those >5  x  104 cells/cm  2, respectively, at har- 
vest. Cells received 6 ml/dish of a medium containing 5  ~tCi/rrd of [aH]- 
glucosamine (22.6 Ci/mmol, TRK.398) and were incubated for 24 h under 
the culture conditions. A set of cultures was preincubated in a medium sup- 
plemented with 0.2% serum for 24 h before labeling with [3I-l]glucosamine 
in 6 ml/disb of a  medium supplemented with 0.2%  serum. GAG's from 
extracellular  (medium-secreted and  trypsin-removed)  and  intracellular 
(cell-associated  after trypsinization) pools were isolated by alkali treatment, 
protease digestion, and precipitation with cetylpyridinium chloride as previ- 
ously described (31). The content of  hexuronlc acid (HexUA) in GAG prepa- 
rations was determined by the method of Bitter and Muir (4) and, if neces- 
sary,  was corrected by subtracting the amount of serum-derived HexUA 
using the value of 55.6 IxM HexUA in serum. 
At the onset and the end of glucosamine labeling, cells were washed 
twice with Dulbecco's Ca  2÷- and Mg2+-free PBS and harvested by trypsin- 
ization (followed by counting the number of cells with a hemocytometer) 
or by dissolving in an appropriate volume of 0.3 N KOH at 37°C for 1 h. 
The lysate of  the KOH treatment was neutralized with HCI and assayed with 
a protein assay kit (Bio-Rad Laboratories, Richmond, CA). An aliquot of 
the lysate from the initial cell layer was processed for isolation of GAG's 
as described above to determine the initial GAG content in the cell layer. 
GAG preparations were dissolved in an appropriate volume of water and, 
with or without addition of authentic GAG's, their aliquots containing ,,ol 
nmol HexUA equivalent were subjected to electrophoresis on a cellulose 
acetate membrane in 0.1  N  H2SO4 at  1 mA/cm for  120  min  (33).  The 
membrane was stained in 0.1% Alcian Blue 8GX in 0.1% acetic acid for 10 
rain, destained in 0.1% acetic acid, lightly blotted with filter papers, and 
air dried (17). For the samples mixed with authentic GAG's,  spots of in- 
dividual GAG's were cut offand directly transferred to a vial to measure ra- 
dioactivity by liquid scintillation counting. The samples without authentic 
GAG's were analyzed by densitometry as follows. A dried membrane was 
immersed in liquid paraffin, put between glass plates, and analyzed with a 
TLC scanner (CS-910 and C-R3A Chromatopac, Shimadzu Corp., Kyoto, 
Japan).  Authentic GAG's (porcine skin HA,  whale cartilage chondroitin 
4-sulfate, shark cartilage chondroitin 6-sulfate, porcine skin dermatan sul- 
fate, and bovine kidney HS) were used to calibrate absorbance at 595 urn, 
which was linear with concentration of HA, HS, and chondroitin 4-sulfate 
up to 1.3, 1.1, and 0.8 nmol, respectively, as HexUA equivalent per spot. 
As the specific absorbance of chondroitin 4-sulfate, chondroitin 6-sulfate, 
dermntan sulfate, and HS was 1.87, 1.88, 1.85, and 1.42, respectively, taking 
that of HA as 1.00, chondroitin 4-sulfate was used as a standard for GalAG's. 
Contents of individual GAG's (as HexUA equivalent) in serum were deter- 
mined by the same method (HA, 13.8 ktM; HS, 30.4 laM; GalAG's, 16.2 ~tM) 
and, if necessary, GAG contents in the samples were corrected by subtract- 
ing the values corresponding to the amount of each GAG derived from se- 
rum. In an experiment, the cellulose acetate membrane was removed from 
glass plates, washed in benzene, and air dried. Spots of the samples (corre- 
sponding to authentic GAG's on a separate lane) were cut off for liquid scin- 
tillation counting. 
Assay of  GAG Synthesis in a Cell-free System 
The activity of the enzyme systems synthesizing individual GAG species 
was assayed as follows: sparse, dense, serum-starved sparse, and serum- 
starved dense cultures were prepared in 4-16 dishes in a fashion similar to 
the assay of GAG synthesis by intact cells. Cell layers were washed twice 
with 0.15 M NaCI, scraped in 0.15 M NaCI with a piece of Teflon sheet, 
pelleted by centrifugation (1,400 g  for 5 min), and immediately stored at 
-80°C. Aliquots were directly subjected to the assay of protein content as 
described above. The cell pellets were thawed in an appropriate volume of 
0.25 M sucrose to obtain cell suspensions containing 2-5 mg/ml of cellular 
proteins. These were stored at -80°C and thawed just before assay to use 
as enzyme sources for cell-free GAG synthesis. 
The reaction mixture for cell-free GAG synthesis in a final volume of 100 
I~1 contained 50 I~1 of enzyme source in 0.25 M sucrose, 50 mM Hepes, 
pH 7.4,  10 mM MgC12, 4 mM MnCI2,  5 mM CaC12, 0.2 mM uridine 5'- 
diphospho-N-acetylglucosamine (Sigma Chemical Co.,  St.  Louis, MO), 
0.2  mM  uridine  5'-diphospho-N-acetyl-galactosamine (Sigma  Chemical 
Co.), 0.1 mM adenosine 3'-phosphate 5'-phosphosulfate (Sigma Chemical 
Co.), 10 mM ATP (Sigma Chemical Co.), and 4.6 IxM uridine 5'-diphospho- 
[14C]glucuronic acid (UDP-[r4CIGlcUA;  272 mCi/mmol, CFB.106)  (of. ref- 
erence 49).  Cell-free GAG synthesis was performed at 37"C for 1 h with 
an enzyme source containing ,,o100 ~tg of cellular proteins in 100 Ixl of the 
above reaction mixture, unless otherwise indicated. In all subsequent sec- 
tions, the name of sugars combined with UDP is abbreviated as UDP-sugar. 
After the reaction, the mixture was immediately cooled on ice, mixed 
with 10 gl of 5 N NaOH, and incubated overnight at 4°C. Then 10 ltl of 
acetic acid was added and the sample was lyophilized and dissolved in an 
appropriate volume of water. Its aliquots (50 Ixl each) were incubated at 
37°C for 4 h with 50 gl of either water (control), hyaluronidase solution 
(Streptomyces hynluronidase [44], EC 4.2.2.1; 20 turbidity reducing units 
(TRU)Iml in  100 mM Na acetate buffer, pH 5.0) or heparanase solution 
(Flavobacterium heparan sulfate lyase [21], EC 4.2.2.8; 10 U/mi in 50 mM 
Tris-HCl, 50 mM Na acetate,  1.25 mM CaCI2,  and 0.25 mg/ml of BSA, 
pH 7.5). Another aliquot was incubated at 37"C for 4 h with 50 ktl of chon- 
droitinase solution (Proteus chondroitinase ABC [59], EC 4.2.2.4; 1 U/ml 
in the same buffer as heparanase), followed by an additional treatment with 
hyaluronidase solution (50 ~tl) at 37°C for 4 h. 
Each of the digested samples was lyophilized, dissolved in 25 I.tl of 1 N 
NaOH, and spotted onto a filter paper (No. 50, Toyo Roshi, Tokyo, Japan) 
with 40 txl of a mixture of propanoic acid and water (1:1, vol/vol) (or 1% 
SDS), which was used to wash the sample tube. Descending paper chroma- 
tography was carried out overnight with the first solvent (1-butanol/etha- 
nol/water [52:32:16, vol/vol/vol]) to remove salts in the sample (18) and then 
again  overnight  with  the  second solvent (1-butanol/propanoic acid/1  N 
NI-I4OH (1:2:2,  vol/vol/vol]). After air drying the paper, the spot at the 
origin was cut off for liquid scintillation counting. The amounts of GAG spe- 
cies synthesized in the cell-free system were calculated from the differences 
in the radioactivity between the samples treated or untreated with GAG 
lyases. 
Assay of  Inhibition of CeU-free HA Synthesis 
(HAS Inhibition) 
Combinations of enzyme sources were used in the above assay of HA syn- 
thesis in a cell-free system to examine the presence of HAS modulator. A 
source from sparse WI-38 CT-1 cells (25 ~tl; used as the target enzyme sys- 
tem) was mixed with 25 ~tl of another source (with a comparable protein 
content) or 0.25  M sucrose (control). Then substrate solutions were added 
to a final volume of 100 I~1 to obtain a cell-free HA synthesis. The amount 
of HA synthesized by each combination was determined as described above 
and the change in cell-free HA synthesis due to mixing the cells was esti- 
mated as described in the footnote to Table V. 
A nalysis of Cell Proliferation 
Cells were inoculated at various cell densities into 6-well plates (8 cm2/ 
well, No. 3506;  Costar, Cambridge, MA) containing 15-ram glass cover- 
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Cells were then stimulated to proliferate by feeding 2 ml/well of a medium 
containing 1-10% serum and 0.1  IxCi/ml of [3H]thymidine (21.0 Ci/mmol, 
TRK. 296). At intervals coverslips were removed, washed three times with 
PBS, and fixed in 60% aqueous methanol at -20"C overnight. Then they 
were washed twice with 60% methanol and 100% ethanol, air dried, and 
mounted on a slide glass. The samples were processed for autoradiography 
using NR-M2 emulsion (Konishiroku Photo Ind. Co., Tokyo, Japan) accord- 
ing to the manufacturer's instruction (with exposure for 7 d at 4°C) and 
stained with a 20-fold dilution of Giemsa solution (No. 9204,  E. Merck, 
Darmstadt, Federal Republic of Germany). About 200 cells on each cover- 
slip from triplicate samples were examined under a microscope to determine 
the percentage of nuclei labeled with silver grains. 
Induction of  HAS Inhibition 
Cells were inoculated at a split ratio of 1:8 into 90-mm dishes or into 6-well 
plates (containing coverslips or not). 2 d later the cells received a medium 
containing 0.2%  serum (6 ml/dish or 1 ml/well) with or without 1 pg/ml 
of cycloheximide (C6255; Sigma Chemical Co.) or 0.2 I~g/ml of actinomy- 
cin D (A4262; Sigma Chemical Co.). At intervals, cells in 90-ram dishes 
were harvested for assay of HAS activity and HAS inhibition as described 
earlier. 
Parallel cultures in 6-well plates were starved of serum as described 
above and incubated for 6 h with 0.1 ~Ci/mi of ~C-amino acid mixture (55 
Ci/g atom carbon, CFB.  104) and 1 ~Ci/ml of [3H]uridine  (40.0 Ci/mmol, 
TRK. 410). The cells were washed twice with PBS, fixed in 7%  (wt/vol) 
TCA on ice for 30 min, washed twice with ice-cold 7% TCA, and dissolved 
in 0.5 mi of 0.3  N KOH at 37°C for 1 h. Each cell lysate, combined with 
0.5 ml of 0.3 N HCI and 1 ml of PBS to wash the well, was transferred to 
a vial for liquid scintillation counting. 
At intervals after the onset of serum starvation, cells cultured on cover- 
slips in 6-well plates received 10 gl of [3H]thymidine in PBS to a final con- 
centration of 1 I.tCi/ml and incubated for 1 h. The coverslips were then sam- 
pled and processed for autoradiography as described above. 
Results 
Changes in Cell Proliferation with Different 
Cell Densities and Serum Concentrations 
We  have  reported  that  the  growth  of WI-38  CT-1  cells 
(gamma ray-transformed human fibroblasts) is relatively in- 
susceptible to cell crowding, whereas the growth of WI-38 
cells  (normal human  fibroblasts)  markedly decreases  with 
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Figure L  Changes in transition rate  and prereplicative  period of 
normal (WI-38) human fibroblasts with different serum concentra- 
tions. Sparse WI-38 cells cultured in a medium containing 0.1% se- 
rum for 2 d were stimulated  to proliferate  by elevating serum con- 
centration to 1 (v), 2 (zx), or 10% (o) at 0 time (indicated  by an 
arrow) and continuously incubated  in the presence of l~H]thymi  - 
dine. At intervals,  cells were sampled to determine the percentage 
of unlabeled  nuclei as described in Materials  and Methods (n =  3; 
short bars indicate  SEM's).  According to the model of Smith and 
Martin  (53),  transition  rate  at which cells  emerge from the Go 
phase to enter the S phase is presented  as a slope of the logarithm 
of the percentage  of unlabeled  nuclei  and prereplicative  period as 
an interval  from 0 time to the time at which the slope changed. 
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Figure 2. Changes in transition rate (A) and prereplicative  period 
(B) of normal (WI-38, open symbols) and transformed (WI-38 CT- 
1, closed symbols) human fibroblasts  with different cell densities 
and serum concentrations (o and e, 10%; A, 1%; [] and l, 0.1%). 
Transition  rate and prereplicative  period were obtained from such 
experiments  as that shown in Fig.  1 and were plotted  as a function 
of cell density at 0 time. 
increasing  cell  density,  and  that  serum  starvation  brings 
about  growth  reduction  for both  (34).  To  investigate  the 
above observation in detail, transition rate and prereplicative 
period, which are parameters of a cell's proliferative activity, 
were determined at various cell densities and serum concen- 
trations. Fig. 1 shows an example of the diagrams used to cal- 
culate these parameters.  Transition rates and prereplicative 
periods obtained from such diagrams for other experiments 
are presented in Fig.  2. 
Reducing serum concentration led to a decrease in transi- 
tion rate of transformed cells (Fig. 2) as well as normal cells 
(Fig.  1). Increasing cell density brought about a marked de- 
crease in transition rate of normal cells virtually in inverse 
proportion to cell density (the coefficient of correlation of the 
reciprocal  of transition  rate  to cell  density  was  +0.957). 
Concerning  10%  serum-supplied  transformed  cells,  there 
appears to be an increase in transition rate with increasing 
cell densities followed by a gradual decline in transition rate 
at densities above 1.3  x  104 cells/cm  2 (for the latter change, 
the coefficient of correlation of transition rate to cell density 
was -0.931). As transition rate of transformed cells at densi- 
ties up to 3.1  x  104 cells/cm: was higher than or compara- 
ble to that of rapidly growing normal cells, transformed cells 
were very proliferative in the presence of 10%  serum until 
their density became so high that they piled up in a multilayer 
(5.8  x  104 cells/cm2).  Interestingly,  it appears  that at low 
serum concentrations such as 1 and 0.1%, transformed cells 
continuously decreased in transition rate with increasing cell 
densities from 0.25  x  104 cells/cm  2 to 5.8  x  104 cells/cm  2. 
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Various Cell Cultures 
GAG content (nmol HexUA/dish) 
Cell strain  Culture condition  Initial  Final  Synthesized  Radioactivity  incorporated  Specific radioactivity 
@m/dish  dpm/nmol HexUA 
WI-38  Sparse  7.9  95.9*  54.6  545,000*  9,980 
Crowded  20.8  203.9  149.7  1,164,000  7,780 
WI-38 CT-1  Sparse  1.7  50.6  15.5  438,000  28,300 
Crowded  9.6  106.0  63.0  1,813,000  28,800 
WI-38  Sparse  4.5  81.5~  43.6  503,000~  11,560 
Serum-starved sparse  12.2  31.4  18.5  170,000  9,210 
WI-38 CT-1  Sparse  3.2  77.0  40.4  1,530,000  37,900 
Serum-starved sparse  4.5  20.1  14.9  387,000  26,000 
Cells were cultured in the presence of [3H]glucosamine for 24 h under various culture conditions.  GAG's were isolated from the cell layer harvested at the onset 
of labeling and from the whole culture harvested at the end of labeling as described in Materials and Methods. HexUA content and radioactivity in the GAG prepara- 
tions were determined by the carbazole method and liquid scintillation counting, respectively. As the GAG preparation from the final whole culture includes preexis- 
tent GAG's (derived from serum and the initial cell layer),  the amount of "synthesized" GAG's was obtained by subtracting both the "initial" GAG content and 
the amount of serum-derived GAG's (33.4 nmol, but for serum-starved cultures 0.7 amol) from the "final" GAG content. For details see Materials and Methods. 
* Mean of duplicate determination (standard errors for GAG content and radioactivity were <20 and  19%  of the mean,  respectively). 
Mean of triplicate determination (standard errors for GAG content and radioactivity were <11 and 6% of the mean, respectively). 
These changes in transition rate are consistent with those in 
the growth rate based on the net cell number (34). 
On the other hand, prereplicative period of both normal 
and transformed cells was slightly shortened by increasing 
cell density and was virtually unaffected by changing serum 
concentration.  These results  indicate that the rate of cell 
growth is reflected by transition rate rather than prereplica- 
tive period in the present experiments. 
Estimation of  GAG Synthesis 
by Precursor Incorporation 
In  this  study  we  measured  the  incorporation  of labeled 
glucosamine into GAG's to estimate the amount of synthe- 
sized GAG's. Under the present conditions, incorporation of 
labeled glucosamine into each GAG species (on the basis of 
cell number) increased linearly up to at least 24 h of incuba- 
tion and radioactivity in each GAG species in the cell layer 
reached a plateau by 7 h (for HA and GalAG's) or 24 h (for 
HS) after the onset of incubation (data not shown).  When 
cells were cultured for 24 h in the presence of [3H]glucos- 
amine, washed, and then chased in an isotope-free medium 
for 24 h, the radioactivity in GAG's preexistent in the cell 
layer was completely recovered in the GAG preparation after 
chasing (e.g.,  106% of the total; 26% in cells and 80% in 
medium) (data not shown),  indicating that there was  little 
degradation of GAG's in the cell cultures examined. These 
observations suggest that the rate of glucosamine incorpora- 
tion parallels the rate of GAG synthesis. However, it has been 
demonstrated that the specific radioactivity of UDP-sugars, 
the final precursors for GAG synthesis, differs between cul- 
ture conditions (24, 60), leading to a dissociation of the ap- 
parent isotope incorporation from the net amount of synthe- 
sized GAG's. 
To examine this issue, the net content of GAG's was deter- 
mined  as  HexUA  equivalent  by  chemical  analysis.  The 
results shown in Table I indicate that the specific radioactiv- 
Table I1. Comparison of GAG Composition Determined by Densitometry with Distribution of  lncorporated Radioactivity 
to GAG Species 
GAG content (nmol HexUA/dish) 
Cell culture  GAG species  Initial  Final  Synthesized  Radioactivity incorporated  Specific radioactivity 
Sparse WI-38 cells 
HA  3.0  64.0  +  5.0*  52.7  (87.7)* 
HS  <1.0  22.9  +  2.7  4.2§  (7.0) 
GalAG's  <1.0  13.4  +  1.7  3.2§  (5.3) 
Crowded WI-38 cells 
HA  6.3  115.4  +  5.3  100.8  (63.5) 
HS  5.2  58.9  +  2.0  35.5  (22.4) 
GalAG's  3.0  35.2  ___  0.7  22.5  (14.2) 
@re~dish  dpm/nmol HexUA 
510,000  +  7,100"  (89.0):~  9,680 
36,000  +  1,200  (6.3)  8,570 
27,300  +  1,100  (4.8)  8,530 
781,600  +  46,200  (62.7)  7,750 
306,100  +  10,700  (24.6)  8.620 
158,000  +  5,600  (12.7)  7,020 
GAG's were isolated from the cell culture incubated with [3H]glucosamine as described in the footnote to Table I. The amount of individual GAG species was 
determined by densitometry after electrophoresis on a cellulose acetate membrane. Then the spot of each GAG on a membrane was cut off to measure radioactivity. 
The amount of "synthesized" GAG species was obtained by subtracting both the "initial" content and the amount of serum-derived GAG (HA, 8.3 nmol; HS,  18.2 
nmol; and GalAG's, 9.7 nmol) from the "final" content.  For details see Materials and Methods. 
* Mean  +  SEM (n  =  2). 
Percentage of the total GAG's. 
§ Calculated taking "initial" as 0.5  nmol. 
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Figure 3.  Changes in GAG synthesis by normal  (A, WI-38)  and 
transformed (B, WI-38 CT-I) human fibroblasts with different cell 
densities. Cells at various cell densities were cultured for 24 h in 
the presence of 10% serum and [3H]glucosamine. GAG's were iso- 
lated from the cell cultures and analyzed as described in the foot- 
note to Table HI. The amount of individual GAG species synthe- 
sized was plotted as a function of cell density at harvest (n  =  2; 
standard errors for the whole GAG's were <28% of the mean), o, 
HA; [], HS; and zx, GalAG's. 
ity of newly synthesized GAG's varies with cell strains,  se- 
rum concentrations, and cell densities.  On the other hand, 
when the percentages of individual GAG species to the total 
amount of synthesized GAG's were compared with the per- 
centages to the total radioactivity incorporated into GAG's, 
they were found to be virtually identical (Table II). 
Although direct determination of the amount of individual 
GAG species would most convincingly indicate the net syn- 
thesis of GAG species, we could not always obtain a reliable 
value for the amount of individual GAG's preexistent in the 
cell layer (which should be subtracted as background) be- 
cause of a methodological limit of sensitivity. Moreover, it 
appears that  densitometric  analysis  failed  to  give correct 
results when the amount of synthesized GAG's was notice- 
ably less the amount of serum-derived GAG's. Therefore, in 
the following experiments, the synthesis of individual GAG 
species was estimated from the net increase in HexUA con- 
tent during glucosamine labeling (corresponding to the total 
amount of synthesized GAG's) and the percentage of radio- 
activity incorporated into each GAG species. 
Changes in GAG Synthesis with Different Cell 
Densities and Serum Concentrations 
The synthesis of individual GAG species was investigated in 
relation to the changes in cell proliferation. Fig. 3 and Table 
III show the changes in GAG synthesis on the basis of cellular 
protein content. 
Increasing cell density from 1.4  x  104 cells/cm  2 to 6.9  x 
104 cells/cm  ~ brought about a marked decrease in HA syn- 
thesis by normal cells in inverse proportion to cell density 
(the coefficient of correlation of the reciprocal of the synthe- 
sized amount to cell density was +0.968), whereas there was 
a gradual decrease in HA synthesis by transformed cells (the 
coefficient of correlation of the synthesized amount to cell 
density was  -0.939).  Concerning  lower cell densities,  we 
could not obtain a reliable value for the net amount of synthe- 
sized HA, although it was observed that incorporation of la- 
beled glucosamine into  HA by transformed cells at a  cell 
density of 0.34  x  104 cells/cm  2 was slightly less (by 19%) 
than at 1.4  x  104 cells/cm  2. These changes in HA synthesis 
at  different  cell densities,  at least higher  than  1.4  x  104 
cells/cm  2,  closely  resemble  the  change  in  transition  rate 
shown in Fig.  2.  Synthesis of HS and GalAG's by normal 
cells and synthesis of GalAG's by transformed cells became 
almost twice with increasing cell density, but changing cell 
density did not affect HS synthesis by transformed cells. 
On the other hand, serum starvation decreased HA synthe- 
sis by normal and transformed cells to about a half, while 
Table III. Changes in GAG Synthesis by Normal (WI-38) and Transformed (WI-38 CT-1) Human Fibroblasts 
Due to Serum Starvation 
GAG synthesized (nmol HexUA/mg cellular protein) 
Cell strain  GAG species  10%  serum  0.2%  serum 
WI-38 
WI-38 CT-1 
Whole GAG's  468  +  89*  475  +  35* 
HA  405  (86.5  ±  1.1)*$  193  (40.8  +  2.9)*$ 
HS  20  (4.3  +  0.4)  156  (33.0  +  1.9) 
GalAG's  43  (9.1  +  0.9)  125  (26.3  +  3.5) 
Whole GAG's  245  ±  19  196  +  18 
HA  188  (76.9  +  1.2)  95  (48.6  +  h4) 
HS  17  (7.1  ±  0.4)  48  (24.7  +  5.1) 
GA1AG's  40  (16.1  -t- 0.8)  52  (26.6  +  3.7) 
Cells were cultured for 24 h in the presence of [3H]glucosamine at a serum concentration of 10 or 0.2%. The total amount of GAG's synthesized during labeling 
.period (shown as "whole GAG's" in this Table) was determined chemically as HexUA equivalent (see Table I) and the percentage of radioactivity incorporated 
into each GAG (shown in parentheses in this Table) was determined by liquid scintillation  counting after electrophoretic separation (see Table II).  The amount 
of individual GAG species synthesized was obtained by dividing the total  amount according to the percentage of each GAG. 
* Mean -t- SEM (n =  3). 
$ Percentage of radioactivity incorporated  into each GAG to the total radioactivity in GAG's. 
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with Different Cell Densities and Serum Concentrations 
UDP-[gC]GIcUA incorporated (pmol/h per mg) 
Sparse cells  Crowded  cells 
Cell strain  GAG species  10%  serum  0.2%  serum  10%  serum  0.2%  serum 
WI-38 
WI-38 CT-1 
HA  24.5  4-  3.5*  10.3  4- 2.0*  14.6  4-  3.0*  Not done 
HS  14.6  4-  2.5  26.7  +  0.6  17.7  +  1.0  Not done 
GalAG's  11.5  4.  2.8  31.4  +  2.8  13.9  +  2.8  Not done 
HA  84.1  4.  2.4  20.1  +  6.6  35.9  4.  1.4  16.6  4-  1.2" 
HS  21.5  +  2.1  26.2  4.  1.0  27.1  ±  1.6  24.4  ±  0.7 
GalAG's  14.5  4.  2.3  32.4  4-  3.8  13.9  4-  1.1  21.4  4-  1.0 
Sparse and crowded cells cultured in a medium containing  10 or 0.2%  serum were scraped and disrupted by freezing and thawing to obtain enzyme sources for 
the assay of cell-free GAG synthesis as described  in Materials and Methods. 
* Mean  +  SEM (n  =  3). 
HS synthesis by both the cells and synthesis of GalAG's by 
normal cells were much enhanced (Table HI). As transition 
rate of both normal and transformed ceils decreased with 
reducing serum concentrations (Figs.  1 and 2), these obser- 
vations indicate that serum starvation as well as increasing 
cell density brought about a change in HA synthesis parallel 
to that in transition rate. It is also of note that the percentages 
of both HS and GalAG's to the whole GAG's increased with 
a reduction in cell growth (the percentage of HA accordingly 
decreased). 
Expressing the above results on the basis of cell number, 
however, produces a somewhat different relation of the syn- 
thesis of HS and GalAG's: the amounts of synthesized HS 
and GalAG's on a per-cell basis,  in some cases, decreased 
with a reduction in cell proliferation, while there was little 
change on a per-protein basis. It may not be valid to describe 
on  such  results  how  the  synthesis  of HS  and  GalAG's 
changed. Nevertheless, the percentages of individual species 
to the total GAG's are the same, regardless of which basis is 
used. Therefore, here we state that a decrease in HA syn- 
thesis and an increase in the percentages of both HS and 
GalAG's  to  the  whole  GAG's  synthesized accompanied a 
growth reduction in normal and transformed human fibro- 
blasts. 
Changes in Synthetic Activity of  GAG's  with  Different 
Cell Densities and Serum Concentrations 
As a modulation of the enzyme systems for GAG synthesis 
is the most probable mechanism for the changes in GAG syn- 
thesis, we examined the synthetic activity of individual GAG 
species,  using  a  cell-free system  with  cells  disrupted  by 
freezing and thawing as enzyme sources. The synthesis of  in- 
dividual GAG species in this system increased linearly up to 
at least 1 h of incubation and up to at least 200 ~tg/100 B1 of 
a final protein concentration (data not shown). Concerning 
the concentration of the  substrate UDP-[t4C]GIcUA, dou- 
bling substrate concentration to 9.2 IxM increased the cell- 
free synthesis of each GAG only slightly (e.g., HA synthesis 
by sparse  and  serum-starved sparse  transformed cells in- 
creased by 8 and 10%, respectively) (data not shown), indi- 
cating  that  GAG-synthesizing enzymes were  subsaturated 
with the substrate at a concentration of 4.6 $tM. In addition, 
the  amount  of UDP-[~C]GlcUA  incorporated into  GAG's 
(and any other macromolecules) was  small (e.g.,  at most 
5.3% of the total in the experiment shown in Table IV) and 
the remainder of radioactivity was recovered as a single peak 
at the same position as authentic UDP-GlcUA by paper chro- 
matography. 
As shown in Table IV, serum starvation brought about a 
marked reduction in cell-free HA synthesis by both normal 
and transformed cells. Although increasing cell density also 
resulted in a reduction in HA synthesis by both types of cells, 
it failed to reduce HA synthesis by transformed cells to the 
lowest level. These changes in cell-free HA synthesis cor- 
related, if not always quantitatively, with the changes in HA 
synthesis by intact cells. As HA synthesis in the present cell- 
free system is thought to reflect the activity of HAS (see Dis- 
cussion), the results of the cell-free HA synthesis indicate 
Table V. Inhibition of  Cell-free HA Synthesis (HAS Inhibition) by Serum-starved Cells 
Cell-free  Apparent 
Source (protein content)  HA synthesis  change  HAS-Inhibition 
pmol/h  %  % 
(1)  Sparse cells  alone (78  txg)  9.70  4-  0.10*(A) 
(2)  Serum-starved cells alone (70  ltg)  1.22  +  0.06  (B) 
(3)  Sparse cells plus serum-starved cells (78 +  70  Ixg)  7.42  4.  0.08  (C)  -32.1(D)  40.2  (E) 
Cell-free HA synthesis by the following combinations of enzyme sources from WI-38 CT-I cells and 0.25 M sucrose (25 BI each) was assayed as described in 
Materials and Methods: (I) sparse ceils plus 0.25  M sucrose; (2) serum-starved sparse cells plus 0.25 M sucrose; and (3) sparse cells plus serum-starved sparse 
cells.  "Apparent change  ~ (D) and "inhibition" (E) were calculated as D  =  100  x  (C-]A+B])/(A+B)  and  E  =  100  x  ([A+B]-C)/A  x  (protein  content of 
[/])/(protein content of [2]), respectively.  HA synthesis by the mixed source  (C) was less than the sum of HA synthesis of the two separate sources (A  +  B). 
* Mean  +  SEM (n  =  3 or 4). 
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Figure 4. Induction of HAS inhibition in transformed (WI-38 CT-1) 
human  fibroblasts by serum  starvation.  Sparse transformed cells 
under the normal culture conditions  (with  10% serum)  were fed 
with a medium containing 0.2% serum at 0 time (indicated by at- 
lOWS). At intervals the cells were harvested to determine HAS activ- 
ity  (A,  o;  n  =  2)  and  HAS inhibition  (B,  o)  as described  in 
Materials and Methods, and simultaneously parallel cultures were 
pulse-labeled with [3H]thymidine for 1 h to measure the percent- 
age of labeled nuclei (A, zx; n =  3) by autoradiography (short bars 
indicate SEM's). To examine HAS inhibition, the cells harvested at 
the indicated time were subjected to the assay of cell-free HA syn- 
thesis in combination with sparse WI-38 CT-I cells (the target) as 
described in the footnote to Table V. 
that HAS activity as well as HA synthesis by intact cells fluc- 
tuated in conjunction with cell proliferation. 
Presence of  HAS Inhibition in Serum-starved Cells 
To investigate the mechanism of the growth-related change 
in HAS activity, we performed cell-free HA synthesis with 
a mixture of enzyme sources from sparse (rapidly growing) 
and  serum-starved  sparse  (growth-reduced)  transformed 
cells.  Table V  shows that the mixture synthesized a  lesser 
amount of HA than the sum of that synthesized by each en- 
zyme source alone (32 % in this experiment). This inhibition 
was specific to HA synthesis, as cell-free synthesis of HS and 
GalAG's by the mixed cells was virtually the sum of their sep- 
arate syntheses (104 and  106%  of the sum, respectively, in 
the above experiment) (data not shown).  This suggests the 
presence of a HA synthesis inhibitor(s) in the serum-starved 
cells. 
Induction of  HAS Inhibition by Serum Starvation 
We thought that the above HAS inhibition might be related 
to growth reduction, as proliferation was low in the serum- 
starved transformed cells. Therefore we investigated the oc- 
currence of HAS inhibition in relation to the change in cell 
proliferation. 
Growing WI-38 CT-1 cells were starved of serum and cell 
proliferation, HAS activity, and HAS inhibition were exam- 
ined as a function of incubation time (Fig. 4).  Here we ex- 
pressed cell proliferation as the percentage of labeled nuclei 
after incubation  with  PH]thymidine  for  1 h,  which  indi- 
cates the percentage of cells in the S phase. The percentage 
of labeled nuclei began to decrease 7 h after the cells were 
starved of serum and stayed at a low level up to at least 19 h. 
HAS activity also markedly decreased by 6 h after the onset 
of serum starvation. On the other hand, HAS inhibition was 
absent initially in the rapidly proliferating cells, but serum 
starvation of the cells led to a high level of HAS inhibition 
6 h  later. 
In addition, we found that treatment of the cells with ac- 
tinomycin D (at a dose to inhibit RNA synthesis by 87%) or 
cycloheximide (at a dose to inhibit protein synthesis by 85 %) 
suppressed the induction of HAS inhibition to 26 or 35 % of 
the  control,  respectively  (Table VI).  In this  experiment, 
however, treatment with these drugs failed to prevent the de- 
crease in HAS activity, as both treated and untreated cells de- 
creased in HAS activity to a similar level 6 h after the onset 
of serum starvation. 
Differences in HAS Inhibition between Cell Strains 
and Culture Conditions 
As the foregoing indicates a close relation between HAS in- 
hibition and the reduction in cell proliferation, we examined 
HAS inhibition in various cell cultures (Table VH). Normal 
human  fibroblasts,  whose  growth  was  suppressed by cell 
crowding or serum starvation, were high in HAS inhibition. 
Also,  BALB/3T3  cells  were high  in HAS inhibition when 
Table VI. Effects of  Actinomycin D and Cycloheximide on the Induction of  HAS Inhibition in WI-38 CT-1 Cells 
Incorporation 
TLme after  HAS 
serum starvation  Treatment  HAS activity  inhibition*  [JH]Uridine  "C-Amino acids 
h  pmol/h per mg  %  @m/well  @m/well 
0  None  59.8  -9.7 
3  None  54.5  5:  2.0*  -2.3 
6  None  35.0:1:0.6  42.3  58,485:1:  744*  1,680  :t: 49* 
6  Actinomycin D  41.9  +  0.9  10.9  8,029  +  339  1,327  +  92 
6  Cycloheximide  25.4  +  1.2  15.0  40,698  +  207  254  :t: 5 
Sparse WI-38 CT-I cells were starved of serum at 0 time and were incubated in the presence or absence of 0.2 ~g/mi of actinomycin D or 1 I~g/ml of cycloheximide 
for the indicated  periods and harvested to determine both HAS activity and HAS inhibition. Parallel  cultures were identically  treated with the drugs in the presence 
of 1 IICi/ml of [aH]uridine and 0.1  IxCi/ml of ~C-amino acid mixture for 6 h after the onset of serum starvation to measure the synthesis of RNAs and proteins. 
For details see Materials and Methods and the footnote to Table  V. 
* Effect on cell-free HA synthesis by sparse WI-38 cr-1  cells, calculated from duplicate assay. 
¢ Mean +  standard error (n  =  2  for "HAS activity" and n  =  3 for "incorporation"). 
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and Transformed Cells under Different Culture Conditions 
Cell strain  Culture  condition  HAS inhibition* 
% 
WI-38  Sparse  11.3 
Serum-starved sparse  62.2 
Crowded  56.8 
WI-38 CT-1  Sparse  2.2 
Serum-starved sparse  45.8 
Crowded  5.3 
BALB/3T3  Sparse  19.7 
Crowded  47.2 
Sources from various cell cultures were assayed for HAS inhibition by mixing 
them with sparse WI-38 CT-I cells (the target enzyme system) as described in 
the footnote to Table V and in Materials and Methods. 
* Effect on cell-free HA synthesis by sparse WI-38 CT-1 cells, calculated from 
triplicate assay. 
their growth was density inhibited (percent increase in cell 
number during 24 h was 128 and 14 % for sparse and crowded 
cells, respectively). Interestingly, there was little HAS inhi- 
bition in crowded WI-38 CT-1 cells. 
Discussion 
In the present study to examine the relation of GAG synthesis 
to cell proliferation, we estimated the synthesis of individual 
GAG species by measuring both the total amount of GAG's 
synthesized by cultured cells during incubation with labeled 
glucosamine (determined chemically as HexUA equivalent) 
and the percentage of radioactivity incorporated into each 
GAG species (determined by liquid scintillation counting af- 
ter electrophoretic separation). It was found that there was 
little degradation of GAG's in the cell cultures examined 
(hence an increase in the total amount of GAG's during the 
labeling period was attributable to the amount of newly syn- 
thesized GAG's) and that the distribution of incorporated ra- 
dioactivity to individual GAG species was  parallel to the 
composition of the newly synthesized GAG's (i.e.,  all the 
GAG species synthesized during the labeling period were 
similar in their specific radioactivity). We consider that these 
facts validate the present estimation of the synthesis of in- 
dividual GAG species. 
Such a determination of GAG species synthesized under 
varying culture conditions demonstrated that changes in HA 
synthesis by both normal and transformed cells in conjunc- 
tion with the alteration of cell density and serum concentra- 
tion noticeably resembled the changes in the proliferation of 
these cells. We consider this to have established the coupling 
of the change in HA synthesis with cell proliferation rather 
than with cell density or cellular transformation in the human 
fibroblasts examined.  Concerning HS  and GalAG's,  how- 
ever, we could draw no conclusion about the relation of their 
synthesis to cell proliferation as interpretation depended on 
whether their synthesis was estimated on the basis of cell 
number or cellular protein content. Nevertheless, the per- 
centages of both HS and GalAG's to the total amount of syn- 
thesized GAG's were found to be elevated by growth reduc- 
tion.  This  growth-related change  in  the balance  in  GAG 
synthesis resulted, at least in part, from the decrease in HA 
synthesis by growth-reduced cells. 
It  appears  that  the  subcellular  composition  of GAG's 
also fluctuated with differing culture conditions: as judged 
from the  radioactivity incorporated  into GAG  species  in 
intracellular  and  nuclear  fractions  after  labeling  with 
[3H]glucosamine  for 24 h, a reduction in cell growth was 
accompanied by a decrease in the percentage of HA to the 
whole GAG's and an increase in the percentage of HS (data 
not shown).  To establish the relation of subceUular  GAG 
composition to cell proliferation, however, the net amounts 
of GAG species in the subcellular pools should be deter- 
mined, because there were differences in the turnover rate 
between GAG species and also in the specific  radioactivity 
of the precursors  for GAG synthesis between cells under 
different culture conditions. 
In this connection, the cell nuclei have been found to con- 
tain GAG's (2,  14, 28,  54)  and recently the presence of a 
uniquely structured HS in the nuclei was demonstrated (10). 
Although the role of GAG's in the nucleus is not clear, HS, 
but not HA or GalAG's, has been revealed to exert a potent 
inhibition on DNA synthesis in isolated nuclei and in cell- 
free systems (12, 13, 58). Thus, it is conceivable that increas- 
ing the predominance of HS in the cell nucleus leads to the 
inhibition of DNA synthesis, presenting the possibility that 
the regulation of cell proliferation involves a change in nu- 
clear GAG composition. In this case, HA synthesis, which 
we found to fluctuate with cell proliferation, may be of pri- 
mary significance in  the  modulation of subcellular GAG 
composition, especially in fibroblasts that mainly synthesize 
HA. Investigation of the change in HA synthesis would then 
provide a clue to the regulation of cell proliferation. 
There may be several possible mechanisms for the growth- 
coupled modulation of HA synthesis. Altering the supply of 
the substrates for GAG synthesis may change the synthesis 
of individual GAG species. However,  HA synthesis fluctu- 
ated quite differently from HS synthesis, in spite of the fact 
that both HA and HS are synthesized of the same substrates, 
UDP-GIcUA  and  UDP-N-acetylglucosamine (19, 40,  49). 
Thus, this presumption is unlikely. Another possibility is a 
growth-related modulation of intracellular pH (5, 37), which 
may affect the activity of  the enzyme system for HA synthesis 
(conventionally termed  "hyaluronate synthetase"  [HAS]). 
According to our examination, however, intracellular pH in 
both WI-38 and WI-38 CT-1 cells was, irrespective of cell 
densities,  7.20-7.24  in  the  presence  of  10%  serum  ar.d 
7.10-7.13 in the presence of 0.2%  serum (our unpublished 
data). This could not explain the density-related change in 
HA synthesis. Furthermore, judging from cell-free HA syn- 
thesis at varying pH's (data not shown), such a difference in 
pH may have little effect on HAS activity. 
On the other hand, analysis of GAG synthesis in a cell-free 
system demonstrated that cell-free HA synthesis by both nor- 
mal and transformed cells exhibits a growth-related change 
similar to HA synthesis by intact cells, suggesting that the 
growth-related change in HA synthesis is mainly attributable 
to a change in the activity of HAS. However, this presump- 
tion needs to be tested, as a deficit in acceptors (including 
primers) for HA synthesis would also affect incorporation of 
the substrate (UDP-[14C]GlcUA) into HA chains. In addi- 
tion, a decrease in the concentration of the labeled substrate, 
preexistence or formation of  unlabeled UDP-GIcUA,  or deg- 
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an apparent change in HA synthesis. 
Concerning the acceptors, the presumed limitation of HA 
synthesis due to a deficit of the acceptors is unlikely, as addi- 
tion of  boiled cell lysate to the reaction mixture did not affect 
the cell-free synthesis of any GAG species. Furthermore, the 
result of experimentation mixing different cells shown in Ta- 
ble V contradicts the above presumption: if both sparse and 
serum-starved cells had an insufficient amount of receptors 
relative to HAS, there could be no acceptors free of HAS in 
both cells. Mixing these cells would not result in a change 
in HA synthesis because of the lack of acceptors. If only 
serum-starved cells were insufficient in acceptors (HAS free 
of acceptors in  serum-starved cells and acceptors free of 
HAS in sparse ceils), mixing these would increase HA syn- 
thesis due to a  coupling of free HAS with free acceptors. 
However, neither was the case. These results are acceptable, 
as there has been no demonstration that HA synthesis in- 
volves acceptors other than nascent HA chains (50) or one 
of  the  substrates  (UDP-GlcUA  or  UDP-N-acetylglucos- 
amine) (36,  48). 
On the other hand, the concentration of UDP-[14C]GIcUA 
decreased little during the reaction as described in Results. 
Preexistence of unlabeled UDP-GIcUA in cell lysates is con- 
sidered to have barely affected HA synthesis, as the activity 
of HA synthesis was determined at such a concentration of 
cell lysates that the rate of HA synthesis was linear; and fur- 
thermore, a fractionation of cells to prepare a crude plasma 
membrane fraction (45) (hence enriched with HAS and free 
of cytosolic substances)  did not change the  ratio  in  HA- 
synthesizing activity between the cells (data not shown). Ac- 
tivities converting UDP-glucose to UDP-GIcUA and degrad- 
ing HA were not detected in the present cell-free system (data 
not shown).  Consistently, addition of D-saccharic acid 1,4- 
lactone (inhibiting 13-glucuronidase  [27])  or 13-NADH (in- 
hibiting  UDP-glucose dehydrogenase [61]) to the  reaction 
mixture had no effect. 
In this connection, there are other enzymes that could af- 
fect cell-free GAG synthesis. However, it is conceivable that 
nucleotide pyrophosphatase (3) and 5'-nucleotidase (9) (both 
suggested to be involved in the termination of HA chain elon- 
gation [48]) may be inhibited in the presence of 10 mM ATP 
and that UDP-GIcUA decarboxylase (16) and UDP-GlcUA 
5-epimerase  (8)  (both  converting  UDP-GIcUA)  may  not 
function in the absence of 13-NAD  +. 
In conclusion, the differences in the cell-free HA synthesis 
between the cells examined were attributable to differences 
in HAS activity and, consequently, it is suggested that the 
growth-related change in  HA synthesis by intact cells re- 
suited from a change in HAS activity. 
Concerning HAS, it has been reported that treatment of 
cultured cells with growth stimulators such as chicken and 
calf sera (38, 55), epidermal growth factor (26), prostaglan- 
din F2~ (39), and CTAP-I and III (51) and with a promoter 
tetradecanoylphorbol acetate (56) brings about an elevation 
of HAS activity, which is suppressed by treatment with ac- 
tinomycin D (39, 55) or cycloheximide (51, 55). These obser- 
vations led one to think that the change in HA synthesis was 
the result of HAS modulation such as formation and turnover 
of the enzyme system. Although the recent study of Mian 
(35)  demonstrated  a  difference  in  phosphorylation  of a 
protein complex synthesizing HA oligosaccharides between 
growing and density-inhibited human fibroblasts, the process 
of HAS modulation has not been established. 
To examine the possibility of this modulation, we inves- 
tigated cell-free HA synthesis using  a  mixture of enzyme 
sources from various cells. Mechanisms for the change in 
HAS activity might be a modulation of HAS itself, modula- 
tion by a factor(s) inhibiting or stimulating the enzyme sys- 
tem,  or both of these.  In the first case,  a  combination of 
different enzyme sources would synthesize an amount of HA 
comparable to the sum of that synthesized by each enzyme 
source alone.  The result,  however, demonstrated that the 
cell-free HA synthesis was considerably reduced by mixing 
enzyme sources from sparse (rapidly growing) and serum- 
starved sparse (slowly growing) WI-38 CT-1 cells. 
The above reduction in cell-free HA synthesis was not due 
to a dilution of some indispensable factor(s) in sparse cells, 
as all the samples were adjusted to the same final volume and 
sucrose concentration. Neither a change in the substrate con- 
centration nor degradation of HA in  the cell-free system 
could account for HAS inhibition as discussed earlier. It is 
noteworthy that the inhibition was specific to HA synthesis, 
as this eliminates a possible attribution of HAS inhibition to 
the proteolysis of HAS. 
Consequently,  it is  likely that  HAS  inhibition  resulted 
from the presence of a factor(s) inhibiting HAS activity. We 
are now examining HAS inhibition in detail, the results so 
far confirming the existence of a HAS inhibitor. This discov- 
ery of a HAS inhibitor would introduce a novel mechanism 
in the growth-related modulation of HA synthesis. Indeed, 
the present examination of normal and transformed human 
fibroblasts under varying culture conditions revealed that the 
cells high in HAS inhibition were also inactive in HA syn- 
thesis.  Furthermore, serum starvation of transformed cells 
brought about induction of HAS  inhibition coincidentally 
with a decrease in HAS activity. These findings suggest that 
HAS inhibition accounts for most, if not all, of the change 
in HA synthesis. Although the suppression of induction of 
HAS inhibition by either actinomycin D  or cycloheximide 
failed to prevent cells from decreasing in HAS activity, this 
might result from the drugs' interference with the formation 
or activation of HAS (55). 
It is  worth mentioning again that cell proliferation de- 
creased coincidentally with the induction of HAS inhibition 
and the decrease in HAS activity, emphasizing their tight 
coupling. In this connection, it is most interesting that HAS 
inhibition was absent in crowded WI-38 CT-1 cells. The pro- 
liferation of the transformed cells was relatively insuscepti- 
ble to (or, at very low densities, rather stimulated by) an in- 
crease in cell density until cells became so crowded that they 
pile up.  This suggests that the proliferation of transformed 
and tumor cells, which are insensitive to cell-to-cell contact 
(41), is suppressed at very high cell densities by other factors 
such as spatial and nutritional limitation (6). It is also sug- 
gestive that WI-38 CT-1 cells cultured at a low serum concen- 
tration exhibited HAS inhibition as well as a continuous de- 
crease in proliferation with increasing cell densities. These 
facts imply that the "normal" regulation of cell proliferation 
involves HAS inhibition. In addition, high HAS inhibition 
was  found in crowded BALB/3T3 cells, whose growth was 
density inhibited. Thus, HAS inhibition may occur not only 
in human fibroblasts but in cells under the "normal" regula- 
tion of cell proliferation. This seems relevant to the view that 
Matuoka et al. Hyaluronate Synthetase Inhibition  1113 some function in the normal cell contributes to the switching 
of cell proliferation to cause the cell to enter the Go phase 
(29). 
Received for publication  19 May 1986, and in revised form 24 November 
1986. 
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